A detailed history of Goldman Sachs Group Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 132,540 shares of RXST stock, worth $4.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132,540
Previous 94,151 40.77%
Holding current value
$4.58 Million
Previous $5.67 Million 15.64%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.78 - $57.04 $1.57 Million - $2.19 Million
38,389 Added 40.77%
132,540 $6.55 Million
Q2 2024

Aug 13, 2024

SELL
$50.42 - $64.29 $1.15 Million - $1.47 Million
-22,839 Reduced 19.52%
94,151 $5.67 Million
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $740,241 - $1.21 Million
20,846 Added 21.68%
116,990 $6.03 Million
Q4 2023

Feb 13, 2024

BUY
$20.91 - $40.9 $670,541 - $1.31 Million
32,068 Added 50.05%
96,144 $3.88 Million
Q3 2023

May 14, 2024

SELL
$27.05 - $33.37 $867,439 - $1.07 Million
-32,068 Reduced 33.35%
64,076 $1.79 Million
Q3 2023

Nov 14, 2023

SELL
$27.05 - $33.37 $990,111 - $1.22 Million
-36,603 Reduced 36.36%
64,076 $1.79 Million
Q2 2023

May 14, 2024

BUY
$16.37 - $28.9 $388,132 - $685,219
23,710 Added 30.8%
100,679 $2.9 Million
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $388,132 - $685,219
23,710 Added 30.8%
100,679 $2.9 Million
Q1 2023

May 14, 2024

SELL
$12.58 - $16.68 $241,221 - $319,839
-19,175 Reduced 19.94%
76,969 $1.28 Million
Q1 2023

May 11, 2023

BUY
$12.58 - $16.68 $968,270 - $1.28 Million
76,969 New
76,969 $1.28 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $956M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.